Forte Biosciences FBRX

$ 18.77 0.59%

Quarterly report 2024-Q3
added 11-14-2024

Forte Biosciences Income Statement 2011-2024 | FBRX

Annual Income Statement Forte Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	23.3 M	20.6 M	29.9 M	380 M	154 M	3.27 B	2.79 B	-	-	-	-	-	-
Shares	36.3 M	21 M	14 M	11.2 M	1.34 M	1.34 M	974 K	-	-	-	-	-	-
Historical Prices	0.64	0.98	2.14	36.4	8	123	154	-	-	-	-	-	-
Net Income	-31.5 M	-13.9 M	-21.7 M	-46.5 M	-4.07 M	-49 M	-38.9 M	-33.5 M	-23.1 M	-	-	-	-
Revenue	-	-	-	-	-	18 M	41 K	49 K	51 K	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-32.5 M	-13.9 M	-21.5 M	-46.3 M	-4.06 M	-45.9 M	-37.6 M	-31.7 M	-23 M	-	-	-	-
Interest Expense	-114 K	-145 K	-222 K	-205 K	-5 K	-	-	-	-	-	-	-	-
EBITDA	-32.5 M	-	-21.4 M	-14.2 M	-4.05 M	-45.2 M	-37.3 M	-31.4 M	-22.7 M	-	-	-	-
Operating Expenses	32.5 M	13.9 M	21.5 M	14.2 M	4.06 M	63.9 M	37.7 M	31.7 M	23 M	-	-	-	-
General and Administrative Expenses	10.6 M	8.3 M	7.63 M	4.22 M	1.38 M	12.8 M	8.56 M	4.52 M	3.83 M	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Forte Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	1.46 M	36.4 M	36.4 M	1.45 M	36.3 M	21 M	21 M	21 M	18.9 M	14.8 M	14.8 M	14.8 M	14.2 M	13.6 M	13.3 M	12.8 M	11.2 M	3.65 M	2.12 B	2.11 M	2.11 B	2.11 B	23 M	23 M	20 M	19.9 M	19.9 M	19.9 M	19.8 M	16.3 M	2.21 M	2.2 M	2.2 M	2.2 M	2.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-8.39 M	-12.5 M	-7.42 M	-	-9.96 M	-8.9 M	-6.75 M	-	-3.4 M	-3.04 M	-2.57 M	-	-7.75 M	-5.81 M	-4.8 M	-	-5.1 M	-34.8 M	-2.05 M	-10.6 M	-690 K	-630 K	-1.18 M	-19.6 M	-383 K	-16.1 M	-12.9 M	-10.8 M	-9.95 M	-9.07 M	-9.07 M	-8.43 M	-9 M	-8.04 M	-8.01 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9 K	9 K	9 K	-	18 M	9 K	9 K	-	10 K	10 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-8.63 M	-12.8 M	-7.8 M	-	-10.2 M	-9.03 M	-6.86 M	-	-3.42 M	-3.02 M	-2.51 M	-	-7.7 M	-5.75 M	-4.74 M	-	-5.01 M	-34.8 M	-2.03 M	-	-684 K	-629 K	-16.9 M	-	1.43 M	-15.3 M	-12.8 M	-	-9.74 M	-8.65 M	-8.55 M	-	-8.53 M	-7.62 M	-7.57 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	237 K	307 K	384 K	-	261 K	138 K	102 K	-	23 K	-15 K	-53 K	-	-52 K	-65 K	-63 K	-	-92 K	-7 K	-23 K	-	-6 K	-1 K	-213 K	-	-301 K	-762 K	-34 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-7.8 M	-	-	-	-	-	-3.42 M	-3.02 M	-2.51 M	-	-7.66 M	-5.72 M	-4.73 M	-	-4.97 M	-34.7 M	-2.01 M	-	-684 K	-629 K	-16.7 M	-	1.85 M	-15.1 M	-12.8 M	-	-9.54 M	-8.52 M	-8.49 M	-	-8.34 M	-7.5 M	-7.51 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	8.63 M	12.8 M	7.8 M	-	10.2 M	9.03 M	6.86 M	-	3.42 M	3.02 M	2.51 M	-	7.7 M	5.75 M	4.74 M	-	5.01 M	34.8 M	2.03 M	10.7 M	684 K	629 K	16.9 M	19.1 M	16.6 M	15.3 M	12.9 M	10.7 M	9.75 M	8.66 M	8.56 M	7.98 M	8.54 M	7.63 M	7.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.76 M	7.08 M	3.45 M	-	3.85 M	1.9 M	2.07 M	-	2.04 M	1.99 M	1.82 M	-	2.04 M	2.22 M	1.42 M	-	1.32 M	760 K	673 K	-	331 K	319 K	4.45 M	-	4.32 M	2.57 M	2.42 M	-	2.18 M	2.03 M	1.94 M	-	956 K	1.1 M	1.11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency